Michael J. Fine, MD

home / authors / michael-j-fine-md

Articles

January 25th 2022

Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis

Robert Zivadinov, MD, PhD Michael J. Fine, MD Krishna R. Patel, PharmD, RPh Neil Minkoff, MD

March 24th 2014

Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)

Jeffrey L. Cummings, MD, ScD Michael J. Fine, MD Igor D. Grachev, MD, PhD C. Rick Jarecke, PharmD Meridith K. Johnson, MSc Phillip H. Kuo, MD, PhD Joyce A. Oberdorf Michael Rezak, MD, PhD Da

August 12th 2013

Cost of Care for Malignant and Benign Renal Masses

Aviva G. Asnis-Alibozek, PA-C Michael J. Fine, MD Paul Russo, MD Trent McLaughlin, BSc(Pharm), PhD Eileen M. Farrelly, MPH Norman LaFrance, MD William Lowrance, MD, MPH

Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: November 1st 2024 | Updated: November 21st 2024

Table Multiple Myeloma Trials November 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions